###begin article-title 0
###xml 20 25 <span type="species:ncbi:9606">Human</span>
CTIP2 Expression in Human Head and Neck Squamous Cell Carcinoma Is Linked to Poorly Differentiated Tumor Status
###end article-title 0
###begin p 1
Conceived and designed the experiments: GI AKI. Performed the experiments: GI CW xL RM. Analyzed the data: GI JA AKI. Contributed reagents/materials/analysis tools: ML BW JA AKI. Wrote the paper: GI AKI. Intellectual advice during the course of the study: ML. Critically read the manuscript: BW.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 454 459 <span type="species:ncbi:9606">human</span>
We have demonstrated earlier that CTIP2 is highly expressed in mouse skin during embryogenesis and in adulthood. CTIP2 mutant mice die at birth with epidermal differentiation defects and a compromised epidermal permeability barrier suggesting its role in skin development and/or homeostasis. CTIP2 has also been suggested to function as tumor suppressor in cells, and several reports have described a link between chromosomal rearrangements of CTIP2 and human T cell acute lymphoblast leukemia (T-ALL). The aim of the present study was to look into the pattern of CTIP2 expression in Head and Neck Squamous Cell Carcinoma (HNSCC).
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 192 197 <span type="species:ncbi:9606">human</span>
In the present study, we analyzed CTIP2 expression in human HNSCC cell lines by western blotting, in paraffin embedded archival specimens by immunohistochemistry (IHC), and in cDNA samples of human HNSCC by qRT-PCR. Elevated levels of CTIP2 protein was detected in several HNSCC cell lines. CTIP2 staining was mainly detected in the basal layer of the head and neck normal epithelium. CTIP2 expression was found to be significantly elevated in HNSCC (p<0.01), and increase in CTIP2 expression was associated with poorly differentiated tumor status. Nuclear co-localization of CTIP2 protein and cancer stem cell (CSC) marker BMI1 was observed in most, if not all of the cells expressing BMI1 in moderately and poorly differentiated tumors.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 320 321 320 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 237 242 <span type="species:ncbi:9606">human</span>
We report for the first time expression of transcriptional regulator CTIP2 in normal human head and neck epithelia. A statistically significant increase in the expression of CTIP2 was detected in the poorly differentiated samples of the human head and neck tumors. Actual CTIP2, rather than the long form of CTIP2 (CTIP2L) was found to be more relevant to the differentiation state of the tumors. Results demonstrated existence of distinct subsets of cancer cells, which express CTIP2 and underscores the use of CTIP2 and BMI1 co-labeling to distinguish tumor initiating cells or cancer stem cells (CSCs) from surrounding cancer cells.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 378 381 378 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-AhmedinJemal1">[1]</xref>
###xml 383 386 383 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Marur1">[2]</xref>
###xml 608 611 608 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Marur1">[2]</xref>
###xml 613 616 613 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Spitz1">[3]</xref>
###xml 875 878 875 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Forastiere1">[4]</xref>
###xml 1040 1043 1040 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Jemal1">[5]</xref>
###xml 1045 1048 1045 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Patel1">[6]</xref>
###xml 1197 1200 1197 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Friedlander1">[7]</xref>
###xml 1202 1205 1202 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Rodrigo1">[8]</xref>
###xml 1207 1210 1207 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Schliephake1">[9]</xref>
###xml 1414 1418 1414 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Chang1">[10]</xref>
###xml 1610 1614 1610 1614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Chang1">[10]</xref>
###xml 423 430 <span type="species:ncbi:4097">tobacco</span>
###xml 507 527 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 529 532 <span type="species:ncbi:10566">HPV</span>
###xml 539 545 <span type="species:ncbi:9606">people</span>
###xml 1445 1465 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 1467 1470 <span type="species:ncbi:10566">HPV</span>
###xml 2071 2079 <span type="species:ncbi:9606">patients</span>
Head and neck squamous cell cancers (HNSCC) are the sixth most common cancers in the world and are a major cause of significant morbidity. In the United States alone, Head and neck cancers account for less than 5% of all cancers and for less than 3% of all cancer deaths. For cancers of the oral cavity and pharynx alone 35,310 new cases and 7,590 deaths are estimated for 2008 [1], [2]. Although, HNSCC has been linked to tobacco and betel nut use, alcohol consumption, frequent mouthwash use, exposure to human papillomavirus (HPV), and people with history of smoking and alcohol use are at a greater risk [2], [3]. Genetics and other risk factors may also be associated with the pathogenesis of the disease. New approaches in the treatment of locally advanced HNSCC include chemotherapy and curative treatment to achieve organ preservation and to improve overall survival [4]. Inspite of advances in surgical and other treatments that enhance quality of life and moderating pain, survival rates are not improving for this type of cancer [5], [6]. There has been no significant improvement in 5-year survival over the past 20 years, despite aggressive and multidisciplinary treatment approaches [7], [8], [9]. Research on Molecular biology has provided us with large number of biomarkers that can provide information related to prognosis, treatment options, recurrence and development of secondary primary tumor [10]. Although biomarkers like human papillomavirus (HPV) and EGFR are well studied, their use in therapeutics is still not exploited successfully for efficient management of head and neck cancer [10]. New techniques are being developed to analyze simultaneously huge number of markers which should expand our knowledge of the biology of these cancers. Basic research efforts in terms of identifying novel genes with an altered expression pattern and having a role in critical biological processes such as proliferation and differentiation, disease progression and metastasis of tumors are needed to facilitate the diagnosis, prognosis and therapy of HNSCC patients.
###end p 9
###begin p 10
###xml 0 1 0 1 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 8 9 8 9 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</underline>
###xml 18 19 18 19 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">u</underline>
###xml 27 28 27 28 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</underline>
###xml 36 37 36 37 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</underline>
###xml 50 51 50 51 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</underline>
###xml 67 68 67 68 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</underline>
###xml 79 80 79 80 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</underline>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Avram1">[11]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Avram2">[12]</xref>
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Cismasiu1">[13]</xref>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-ToparkNgarm1">[14]</xref>
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 655 659 655 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Wakabayashi1">[15]</xref>
###xml 874 878 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-ToparkNgarm1">[14]</xref>
###xml 880 884 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Senawong1">[16]</xref>
###xml 1151 1155 1151 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Przybylski1">[17]</xref>
###xml 1261 1265 1261 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Wakabayashi1">[15]</xref>
###xml 1368 1372 1368 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Satterwhite1">[18]</xref>
###xml 1589 1593 1589 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Golonzhka1">[19]</xref>
###xml 1595 1599 1595 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Leid1">[20]</xref>
###xml 1728 1732 1728 1732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Golonzhka2">[21]</xref>
###xml 2362 2384 2362 2384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wound that never heals</italic>
###xml 2386 2390 2386 2390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Dvorak1">[22]</xref>
###xml 0 7 <span type="species:ncbi:9031">Chicken</span>
###xml 353 358 <span type="species:ncbi:10090">mouse</span>
###xml 363 368 <span type="species:ncbi:9606">human</span>
###xml 709 714 <span type="species:ncbi:9606">human</span>
###xml 973 978 <span type="species:ncbi:9606">human</span>
###xml 1101 1106 <span type="species:ncbi:9606">human</span>
###xml 1197 1201 <span type="species:ncbi:10090">mice</span>
###xml 1347 1352 <span type="species:ncbi:9606">human</span>
###xml 1439 1444 <span type="species:ncbi:10090">mouse</span>
###xml 1601 1605 <span type="species:ncbi:10090">Mice</span>
###xml 1780 1785 <span type="species:ncbi:10090">mouse</span>
###xml 2070 2075 <span type="species:ncbi:9606">human</span>
###xml 2602 2607 <span type="species:ncbi:9606">human</span>
###xml 2677 2682 <span type="species:ncbi:9606">human</span>
###xml 2897 2902 <span type="species:ncbi:9606">human</span>
Chicken ovalbumin upstream promoter-transcription factor (COUP-TF)-interacting protein 2 (CTIP2, Bcl11b) is a transcriptional regulator (zinc finger protein) that functions by direct, sequence-specific DNA binding activity or by recruitment to the promoter template by interaction with COUP-TF family member [11], [12], [13], [14]. The CTIP2 gene (both mouse and human) contains 4 exons and the majority of the CTIP2 open reading frame is encoded by exon 4. Kominami's group has reported two alternatively spliced transcript variants, which encode distinct isoforms called CTIP2 long (containing exon1, 2,3 and 4) and CTIP2 short (lacking exons 2 and 3), [15]. Actual CTIP2 is the one lacking exon 3. SK-N-MC human neuroblastoma cells and Jurkat cells are known to endogenously express two splice variants of CTIP2 with a molecular weight of 95.5 and 88.5 kDa, respectively [14], [16]. Bcl11b has been suggested to function as tumor suppressor in cells, primarily based on human loss of homozygosity (LOH) studies. Several reports have described a link between chromosomal rearrangements of CTIP2 and human T cell acute lymphoblastic leukemia (T-ALL) [17]. An association between p53 and CTIP2 in mice has been implicated in the development of thymic lymphomas [15] and the amplification and/or translocation of CTIP2 is thought to play a role in human leukemogenesis [18]. Recently, it has been shown that CTIP2 is expressed early during mouse development as well as in the adult animal, and in both cases, expression is most predominant in the skin/epithelial structures, CNS and thymus [19], [20]. Mice lacking CTIP2 die at birth and exhibit epidermal differentiation defects and a compromised epidermal permeability barrier [21]. Moreover, CTIP2 expression in adult wild type mouse skin was observed to increase dramatically during wound healing, and in pathological conditions particularly in the proliferating cells of the wound bed (Ganguli-Indra et al., unpublished work). Taken together, these results demonstrate that CTIP2 could be of potential importance in human health and highlight the need for additional information regarding their function and expression patterns in pathological diseases and cancer. Since CTIP2 was upregulated in our wound healing experiments and as wound healing and cancer have key similarities where cancer is defined as "wound that never heals" [22], we were interested to look at CTIP2 expression in HNSCC. The main aim of this work is to understand the cellular and molecular basis of CTIP2 overexpression in HNSCC and to establish it as a novel biomarker in human HNSCC. In this study, we have determined CTIP2 expression in several human normal, and HNSCC cell lines. We also evaluated CTIP2 expression pattern by immunohistochemistry (IHC) and qRT-PCR, and determined correlation between clinicopathological factors and CTIP2 expression in a panel of human HNSCC samples.
###end p 10
###begin title 11
Materials and Methods
###end title 11
###begin title 12
Tissue samples
###end title 12
###begin p 13
###xml 717 813 717 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sobin LH, Wittekind C, 1997, TNM classification of malignant tumors. New York. Willey-Liss, Inc.</italic>
###xml 1015 1205 1015 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WHO. Histological typing of upper respiratory tract tumors. K.Shanmugaratnam and LH Sobin (eds.). International Histological Classification of Tumors. 1978, Vol. 19. Springer-Verlag (Geneva)</italic>
###xml 219 227 <span type="species:ncbi:9606">patients</span>
###xml 517 525 <span type="species:ncbi:9606">patients</span>
Paraffin embedded tissue sections from 40 different Head and neck tumors for immunohistochemistry, cDNA samples from 28 head and neck tumor and 10 normal uvula cDNA samples for qRT-PCR (normal uvulas were obtained from patients surgically treated for head and neck cancer and were at least 2 cm. away from the tumor lesion) were obtained following Institutional review board ("Comite de recherche clinique du Centre Paul Strauss." (President: Pr Patrick DUFOUR) approval. Informed written consents were obtained from patients undergoing surgery as a primary treatment, without previous radiation or chemotherapy. The tumors were classified according to TNM stage (tumor, node, metastasis) based on the UICC criteria (Sobin LH, Wittekind C, 1997, TNM classification of malignant tumors. New York. Willey-Liss, Inc.). Histopathological differentiation status was defined depending on the degree of keratin pearl formation, keratinization, overall resemblance to normal squamous epithelium, according to WHO criteria [WHO. Histological typing of upper respiratory tract tumors. K.Shanmugaratnam and LH Sobin (eds.). International Histological Classification of Tumors. 1978, Vol. 19. Springer-Verlag (Geneva)]. Normal samples were collected from the farthest margin of the surgical resections (uvula). All the above mentioned samples were obtained from our collaborator Joseph Abecassis, Centre Paul Strauss, Strasbourg, France.
###end p 13
###begin title 14
Histopathological features of HNSCC
###end title 14
###begin p 15
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Legends for:</bold>
Legends for:
###end p 15
###begin p 16
###xml 0 22 0 22 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Differentiation status</bold>
Differentiation status
###end p 16
###begin p 17
1: well-differentiated
###end p 17
###begin p 18
2: moderately differentiated
###end p 18
###begin p 19
3: poorly differentiated (Poorly differentiated tumors are the less differentiated squamous cell carcinomas).
###end p 19
###begin p 20
4: undifferentiated (correspond to epithelial neoplasms without evidence of squamous or glandular differentiation)
###end p 20
###begin p 21
###xml 0 6 0 6 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T size</bold>
T size
###end p 21
###begin p 22
1 = T1, tumor 2 cm. or less in greatest dimension
###end p 22
###begin p 23
2 = T2, tumor 2 cm. and 4 cm.
###end p 23
###begin p 24
3 = T3, tumor 4 cm
###end p 24
###begin p 25
4 = T4, tumor invades adjacent structures
###end p 25
###begin p 26
###xml 0 13 0 13 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tumor Staging</bold>
Tumor Staging
###end p 26
###begin p 27
Stage I : T1N1M0
###end p 27
###begin p 28
Stage II: T2N0M0
###end p 28
###begin p 29
Stage III : T3N0M0,
###end p 29
###begin p 30
 T1,T2,T3,N1M0
###end p 30
###begin p 31
Stage IV : T4N0,N1M0
###end p 31
###begin p 32
 Any T, N2, N3, M0
###end p 32
###begin p 33
 Any T, any N, M
###end p 33
###begin title 34
Immunohistochemistry
###end title 34
###begin p 35
###xml 372 378 <span type="species:ncbi:9986">rabbit</span>
###xml 478 481 <span type="species:ncbi:10116">rat</span>
###xml 674 680 <span type="species:ncbi:9986">rabbit</span>
###xml 686 689 <span type="species:ncbi:10116">rat</span>
###xml 865 876 <span type="species:ncbi:3704">horseradish</span>
Formalin-fixed and paraffin-embedded HNSCC sections were used in our studies. The sections were deparaffinized in xylene, dehydrated through graded alcohols, and placed in 0.1% hydrogen peroxide to quench any endogenous peroxidase activity. A 5 minute, 750 W microwave pretreatment in citrate buffer (pH 6.0) was repeated 4 times and followed by treatment with 10% normal rabbit serum for 30 minutes. to block nonspecific antibody binding. The slides were then incubated with a rat CTIP2 monoclonal antibody, 1/300 dilution (Abcam product number 18465; clone 25B6) in a humid chamber at 4degreesC overnight. Secondary antibody staining was carried out with a biotin-labeled rabbit anti-rat antibody 1/500 dilution (Jackson Immuno Research Laboratories, INC, catalogue number: 112-065-143) for 2 hrs. at 37degreesC, followed by incubation with a streptavidin-biotin horseradish peroxidase complex (Vector Laboratories, catalog number: SA-5704). Detection was done using DAB+ substrate (Vector: peroxide substrate kit, SK-4100) for 10 minutes. Counterstaining them with Mayer hematoxylin before dehydration and mounting. We analyzed the expression of CTIP2 by comparing the staining intensities between the different samples with and without addition of primary antibody. The staining intensities which were compared were done in the same time and under same conditions. We performed the staining experiment several times and the results were consistent. The analyses of CTIP2 expression were independently performed by two investigators. Staining intensities for each section were as followed: 0, no staining; 1 weak staining; 2 moderate staining; and 3 strong staining. A tumor was considered CTIP2-positive if more than 10% of the tumor cells demonstrated positive nuclear staining.
###end p 35
###begin p 36
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Golonzhka1">[19]</xref>
For immunofluorescence co-staining studies, paraffin sections were rehydrated as described above and processed as described [19]. Slides were then incubated overnight in a humidified chamber with CTIP2 and BMI1 (Abcam: ab14389, 1/100), cytokeratin 10 (Abcam: ab9026, 1/100, ) and Ki-67 (Abcam: ab15580, 1/200) primary antibodies. Primary antibody incubation was followed by three washes with PBST and incubation with fluorescently-labeled [Cy2 (1:250) or Cy3 (1:500) (Jackson ImmunoResearch)] secondary antibody for 2 hours. Nuclei were counterstained with DAPI. Finally, sections were rinsed with PBST, dehydrated through sequential washes in 50%, 70%, 95%, and 100% ethanol and then cleared in xylene. Slides were mounted with DPX mounting media and allowed to dry overnight. Images were captured at 40x magnification using Leica DMRA fluorescent microscope and Hamamatsu C4742-95 digital camera and processed using OpenLab software and Adobe Photoshop 7.0.
###end p 36
###begin title 37
Cell culture and Western blotting
###end title 37
###begin p 38
###xml 575 578 <span type="species:ncbi:10116">rat</span>
Cells were freshly thawed, cultured in their respective medium using the 3T3 protocol. When the cells reached 75 to 80% confluency we change the medium and the next day the cells were harvested and lysed in Laemmli buffer containing a protease inhibitor cocktail (Complete; Roche) and 5 mM Dithiothreitol and boiled. The whole-cell extracts (20 microg protein) were subjected to SDS-PAGE and electro-blotted to nitrocellulose membranes. The membranes were blocked in 5% non-fat dry milk in 10 mM Tris-HCl, pH 7.8, 150 mM NaCl, 0.1% Tween 20, and incubated overnight with the rat monoclonal 25B6 to CTIP2 diluted 1/1000 in the blocking buffer and developed using Super Signal West Pico Chemiluminescent Substrate (Thermo scientific Pierce).
###end p 38
###begin title 39
Cell lines used in this study
###end title 39
###begin p 40
###xml 51 56 <span type="species:ncbi:9606">Human</span>
GM 193: lymphoblast, normal EBV transformed (NIGMS Human Genetic Mutant Cell Repository)
###end p 40
###begin p 41
HUVEC: umbilical cord, endothelium, normal (ATCC CRL-1730)
###end p 41
###begin p 42
GM 3348: skin, normal fibroblasts (NIGMS)
###end p 42
###begin p 43
HS677Tg Fibroblasts, tongue, normal (ATCC CRL-7408)
###end p 43
###begin p 44
###xml 15 20 <span type="species:ncbi:9606">human</span>
Hek-a: Primary human epidermal keratinocytes from adult skin (HEKa, SKU# C-005-5C, Cascade)
###end p 44
###begin p 45
###xml 50 55 <span type="species:ncbi:9606">human</span>
Hacat: Spontaneously immortalized non-tumorigenic human skin keratinocytes (IGBMC cell culture service, DKFZ)
###end p 45
###begin p 46
###xml 6 11 <span type="species:ncbi:9606">human</span>
SCC4: human squamous cell carcinoma, tongue (ATCC CRL-1624)
###end p 46
###begin p 47
Cal27: squamous cell carcinoma, tongue (IGBMC cell culture service, Dr Merlin)
###end p 47
###begin p 48
###xml 7 12 <span type="species:ncbi:9606">human</span>
SCC25: human squamous cell carcinoma, tongue (ATCC CRL-1628)
###end p 48
###begin p 49
###xml 7 12 <span type="species:ncbi:9606">human</span>
SCC15: human squamous cell carcinoma, tongue (ATCC CRL-1623)
###end p 49
###begin p 50
###xml 6 11 <span type="species:ncbi:9606">human</span>
SCC9: human squamous cell carcinoma, tongue (ATCC CRL-1629)
###end p 50
###begin p 51
CAL33: Tongue cancer, elevated EGFR, contact inhibited tongue cancer (IGBMC cell culture service, Dr Merlin)
###end p 51
###begin p 52
KB: Epidermoid carcinoma, mouth (IGBMC cell culture service, Dr Merlin)
###end p 52
###begin p 53
###xml 6 11 <span type="species:ncbi:9606">human</span>
HSC2: human squamous cell carcinoma, oral (IGBMC cell culture service)
###end p 53
###begin p 54
A253: epidermoid carcinoma, submaxillary salivary gland, (ATCC HTB-41)
###end p 54
###begin p 55
HAN HN2: head and neck tumor (IGBMC cell culture service).
###end p 55
###begin p 56
###xml 11 16 <span type="species:ncbi:9606">human</span>
RPMI 2650: human squamous cell carcinoma, nasal septum, quasi-diploid (ATCC CCL-30)
###end p 56
###begin p 57
###xml 9 14 <span type="species:ncbi:9606">human</span>
Det 562: human epithelial carcinoma, pharynx, metastatic (ATCC CRL-7919)
###end p 57
###begin p 58
###xml 6 11 <span type="species:ncbi:9606">human</span>
Fadu: human squamous cell carcinoma, pharynx, primary, tumorigenic (IGBMC cell culture service, Dr Merlin)
###end p 58
###begin p 59
Hep 2: epidermoid carcinoma, larynx (ATCC CCL-23)
###end p 59
###begin p 60
###xml 6 11 <span type="species:ncbi:9606">human</span>
MCF7: human caucasian breast adenocarcinoma (ATCC HTB-22)
###end p 60
###begin p 61
MCF10A: epithelial cell line, mammary gland, non-tumorigenic. (ATCC CRL-10317)
###end p 61
###begin title 62
Quantitative real time PCR (QRT-PCR)
###end title 62
###begin p 63
###xml 49 53 49 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Seghatoleslam1">[23]</xref>
###xml 355 359 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Indra1">[24]</xref>
###xml 606 611 602 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mBmi1</italic>
###xml 630 634 626 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Nowak1">[25]</xref>
###xml 686 687 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 675 687 671 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;<italic>C</italic></sup>
###xml 687 688 675 676 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 717 721 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Li1">[26]</xref>
###xml 753 758 741 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPLPO</italic>
###xml 764 768 752 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 870 876 858 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t test</italic>
###xml 880 885 868 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1 way</italic>
###xml 600 605 <span type="species:ncbi:10090">mouse</span>
Reverse transcription was performed as described [23]. Briefly, reverse transcription was performed using 1 microg total RNA, random primers, and the superscript II RT-PCR system (Life Technologies). qPCR was performed on 1/50 dilutions of the CDNA samples using SYBR Green Supermix (qiagen) in a Applied Biosystems 7500 Real-Time PCR system as described [24]. All reactions were performed in triplicate. Melting curve analyses were performed to ensure the specificity of q-PCR. Primer sets used to test the expression of the two forms of CTIP2 were designed using Primer3 Software. Primers used for mouse mBmi1 were as described [25]. Data analysis was performed using the 2-DeltaDeltaCt method described previously [26]. Ribosomal phospho-protein PO (RPLPO) and HPRT was used as reference gene. qRT-PCR-based gene expression values between the groups were compared by t test or 1 way ANOVA.
###end p 63
###begin title 64
Primers used for Real Time qRT-PCR
###end title 64
###begin p 65
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2<sub>L</sub></italic>
###xml 25 51 25 51 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATCTGTCCCAAGCAGGAGAA-3&#8242;</named-content>
###xml 57 83 57 83 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTCTGACCCTCACCCTGAGT-3&#8242;</named-content>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 108 135 108 135 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCAGGAGAACATTGCAGGTA-3&#8242;</named-content>
###xml 140 167 140 167 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAAATTCATGAGCGGGGACT-3&#8242;</named-content>
CTIP2L(hCTIP2 E2-E3):(F) 5'-ATCTGTCCCAAGCAGGAGAA-3', (R) 5'-GTCTGACCCTCACCCTGAGT-3'; CTIP2(hCTIP2 E2-E4):(F)5'-AGCAGGAGAACATTGCAGGTA-3', (R)5'-GGAAATTCATGAGCGGGGACT-3'.
###end p 65
###begin title 66
Statistical Analysis
###end title 66
###begin p 67
###xml 146 152 146 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t test</italic>
The means and standard errors of qRT-PCR data among different samples were calculated, and the differences between them were determined by either t test or 1 way ANOVA, where p<0.05 is regarded as significant.
###end p 67
###begin title 68
Results
###end title 68
###begin title 69

###end title 69
###begin title 70
###xml 31 36 <span type="species:ncbi:9606">human</span>
Expression pattern of CTIP2 in human HNSCC
###end title 70
###begin p 71
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Golonzhka1">[19]</xref>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Golonzhka2">[21]</xref>
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Golonzhka2">[21]</xref>
###xml 671 678 671 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g001">Fig. 1A</xref>
###xml 843 850 843 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g001">Fig. 1B</xref>
###xml 855 860 855 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">inset</italic>
###xml 982 995 982 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g001">Fig. 1C and D</xref>
###xml 1107 1117 1107 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g001">Figs. 1E&#8211;H</xref>
###xml 1229 1250 1229 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">materials and methods</xref>
###xml 1347 1361 1347 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g002">Fig. 2A and 2B</xref>
###xml 1599 1606 1599 1606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g002">Fig. 2A</xref>
###xml 1853 1859 1853 1859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g001">Fig. 1</xref>
###xml 1861 1872 1861 1872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g002">Fig. 2A &amp; B</xref>
###xml 1877 1884 1877 1884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005367-t001">Table 1</xref>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
In order to localize CTIP2 expression in HNSCC, we performed immunohistochemistry on paraffin embedded sections of Head & Neck tumors (n = 40) and normal samples (n = 12) using high heat antigen retrieval technique and the previously described CTIP2 antibody [19], [21]. Positive staining for CTIP2 was found to be exclusively nuclear. Negative control on sections stained without primary antibody or on skin sections from CTIP2 null mice confirmed no staining [21]. In tumor adjacent normal epithelium CTIP2 was expressed exclusively by the keratinocytes of the basal layer and no expression was detected in cells of the spinous cell layer or granular layer. (Arrows in Fig. 1A, see inset). In dysplasia samples, CTIP2 expression was stronger compared to the normal epithelium and also the expression was extended to the spinous cell layers (Fig. 1B and inset). In well differentiated tumors, CTIP2 staining was observed in the outer layer of the keratinized horn-pearls clusters (Fig. 1C and D). Stronger and homogeneous expression of CTIP2 was observed in moderately and/or poorly differentiated tumors (Figs. 1E-H) compared to the well differentiated tumors. We compared the intensities of CTIP2 staining (0-3) (described in materials and methods) between the adjacent normal, dysplasia and different histological grades of Head & Neck tumor (Fig. 2A and 2B). Out of the 40 different samples we analyzed, 12 of them had adjacent normal epithelium and 4 of them had dysplasia. Compared to normal epithelium, CTIP2 expression was strongly and significantly up-regulated in HNSCC samples (P<0.05) (Fig. 2A). The strongest intensity of CTIP2 staining (level 3) was observed in 11% well differentiated tumors, 25% of the moderately and in 58% of the poorly differentiated tumors compared to no staining of this intensities in adjacent normal epithelium (Fig. 1, Fig. 2A & B and Table 1). Overall, we observed an increase in the intensity of CTIP2 expression with the progression of carcinoma in all our samples analyzed. Thus, our IHC results demonstrates that CTIP2 expression is elevated in HNSCC, and that CTIP2 expression is linked to poor differentiation state of the tumor.
###end p 71
###begin title 72
Immunohistochemical analysis of CTIP2 in HNSCC.
###end title 72
###begin p 73
(A) Expression in adjacent Normal epithelium is restricted to basal cell layers. (B) Expression in dysplasia is stronger than normal and extended to differentiated cell layers. (C-D) In well differentiated tumors, positive staining is restricted to the basal layers at the periphery of the keratinized horn pearl. (E-F) Homogeneous expression of CTIP2 was observed in tumor cells in moderately differentiated tumors. (G-H) Expression of stronger intensities (score 3) of CTIP2 was observed in poorly differentiated tumors. Arrows indicates the CTIP2 positive staining. Yellow dotted lines represents the margin of epidermis and dermis (A), and margin of undifferentiated tumor cell clusters (E) which is magnified in (F). The pictures in the insets (A, B, G and H) are magnified. (Original Magnification: 20x).
###end p 73
###begin title 74
Staining intensities of CTIP2 by immuno-histochemistry in HNSCC.
###end title 74
###begin p 75
###xml 46 66 46 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">materials and method</xref>
Staining intensities were 0-3 as described in materials and method sections. (A) Staining intensities of CTIP2 in normal epithelium (NE), dysplasia and HNSCC. Plotted are mean measurements (+/-S.E.M). *p<0.05. (B) Staining intensities in different histological grades of HNSCC. Plotted are mean measurements (+/-S.E.M). *p<0.05. (C-D) Co-staining of CTIP2 and BMI1 protein. The insets are magnified. Yellow arrows show the CTIP2 and Bmi1 double positive cells. Yellow arrowhead indicates single positive cells. (E) CTIP2 expression in HNSCC cell lines by western blot analysis. CTIP2 antibody recognizes the two isoforms (Long and the actual CTIP2). Green box represents the normal cell lines.
###end p 75
###begin title 76
Staining intensities and percent positivity in normal epithelium and in HNSCC.
###end title 76
###begin p 77
In brackets are the percentages of specific tumor types.
###end p 77
###begin p 78
###xml 186 190 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Lessard1">[27]</xref>
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Molofsky1">[28]</xref>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Park1">[29]</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Chiba1">[30]</xref>
###xml 618 622 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Dovey1">[31]</xref>
###xml 624 628 624 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Glinsky1">[32]</xref>
###xml 630 634 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Godlewski1">[33]</xref>
###xml 636 640 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Mack1">[34]</xref>
###xml 642 646 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Pietersen1">[35]</xref>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Prince1">[36]</xref>
###xml 654 658 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Prince2">[37]</xref>
###xml 940 951 940 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g002">Fig. 2C &amp; D</xref>
###xml 1039 1040 1039 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1043 1050 1043 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g002">Fig. 2C</xref>
###xml 1052 1057 1052 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">inset</italic>
###xml 1145 1149 1145 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmi1</italic>
###xml 1197 1201 1197 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmi1</italic>
###xml 1250 1254 1250 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmi1</italic>
###xml 1270 1277 1270 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005367.s001">Fig. S1</xref>
###xml 1279 1283 1279 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Golonzhka2">[21]</xref>
###xml 1335 1339 1335 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMI1</italic>
###xml 1463 1467 1463 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Avram2">[12]</xref>
###xml 1469 1473 1469 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-ToparkNgarm1">[14]</xref>
###xml 1113 1117 <span type="species:ncbi:10090">mice</span>
###xml 1130 1135 <span type="species:ncbi:10090">mouse</span>
###xml 1319 1324 <span type="species:ncbi:10090">mouse</span>
###xml 1329 1334 <span type="species:ncbi:9606">human</span>
Several reports have shown that polycomb group transcription factor BMI1, is essential for the self renewal of hematopoietic, neuronal stem cells as well as cancer stem/progenitor cells [27], [28], [29]. We hypothesized that CTIP2 might label and modulate self renewal of tumor initiating/cancer stem cells in HNSCC. We therefore performed immunoflourescent co-staining for CTIP2 and BMI1 protein, in well, moderately and poorly differentiated HNSCC samples to see if some of the CTIP2 expressing cells also express the cancer stem cell (CSC) marker BMI1, previously implicated in self renewal and tumorigenesis [30], [31], [32], [33], [34], [35], [36], [37]. Staining for BMI1 was observed mostly in the basal cell layer and decreased towards the outer cell layers. In well and moderate to poorly differentiated tumors, majority of the BMI1 expressing cells showed strong nuclear co-localization of CTIP2 and BMI1 proteins (CTIP2+/BMI1+) (Fig. 2C & D). Besides, some of the cancer cells were stained single positive for CTIP2 (CTIP2+/BMI1-) (Fig. 2C, inset). Interestingly, qRT-PCR performed on the CTIP2 mutant mice skin, using mouse specific Bmi1 primers, showed significant down regulation of Bmi1 expression, suggesting a possible regulation of Bmi1 gene by Ctip2 (Fig. S1) [21]. Furthermore, promoter analyses of mouse and human BMI1 gene revealed presence of several putative CTIP2 binding sites in the proximal and distal promoter region (data not shown) [12], [14]. Altogether, our results suggest existence of distinct subsets of cancer cells which express CTIP2 and underscore the use of CTIP2 and BMI1 co-labeling to identify tumor initiating cancer stem cells (CSC).
###end p 78
###begin title 79
###xml 23 28 <span type="species:ncbi:9606">human</span>
Expression of CTIP2 in human cell lines
###end title 79
###begin p 80
###xml 147 167 147 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">material and methods</xref>
###xml 170 177 170 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g002">Fig. 2E</xref>
###xml 351 358 351 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g002">Fig. 2E</xref>
###xml 741 748 741 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g002">Fig. 2E</xref>
###xml 229 234 <span type="species:ncbi:9606">human</span>
###xml 317 322 <span type="species:ncbi:9606">human</span>
CTIP2 protein expression was detected by western blotting in a panel of cell lines which included normal, HNSCC and other types of carcinomas (see material and methods) (Fig. 2E). We detected weak expressions of CTIP2 in primary human epidermal keratinocytes (Hek-a) and in spontaneously immortalized non-tumorigenic human skin keratinocytes (Hacat) [Fig. 2E]. CTIP2 expression was undetectable in some cell lines from umbilical cord endothelium (HUVEC), skin and tongue fibroblast (GM3348 & HS677Tg). In contrast, very high level of CTIP2 was detected in head and neck cell lines (SCC4, SCC25, HSC2, HAN HN2) and also in other carcinomas such as epidermoid carcinoma from submaxillary salivary gland (A253) and breast carcinoma (MCF7) (see Fig. 2E). Surprisingly, weaker expression was detected in few Head and neck cell lines such as Det562 and Fadu, and no expression at all in RPMI 2650. In most of the cases, CTIP2 expression level was lower than our internal control TATA box binding protein (TBP). Altogether, these results demonstrate that most of the HNSCC cell lines have increased expression of CTIP2.
###end p 80
###begin title 81
Co-labeling of CTIP2 with a proliferation & differentiation marker
###end title 81
###begin p 82
###xml 389 396 389 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g003">Fig. 3A</xref>
###xml 636 643 636 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g003">Fig. 3A</xref>
###xml 1012 1016 1012 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-GanguliIndra1">[38]</xref>
###xml 1154 1161 1154 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g003">Fig. 3B</xref>
###xml 978 983 <span type="species:ncbi:9606">human</span>
To confirm if CTIP2 is linked to the proliferation and differentiation of HNSCC, we used immunofluorescence method to co-label CTIP2 with a proliferation (Ki-67) and a differentiation [cytokeratin 10 (K10)] marker. We observed cytoplasmic expression of K10 either in clusters or in scattered areas of the dysplasia samples and also in tumors with well or moderately differentiated status (Fig. 3A). In dysplasia samples, most of the supra basal layer cells which were positive for CTIP2 also expressed K10. In well to moderately differentiated tumor samples with low level of CTIP2 expression, Cytokeratin 10 was expressed in clusters (Fig. 3A). Some of the CTIP2 positive cells also expressed K10, and some CTIP2 positive cells were negative for K10. In poorly differentiated tumors with less differentiation (less K10 positivity), high levels of CTIP2 was observed which did not express K10. We have recently shown that CTIP2 colabel with proliferation marker Ki-67 in normal human skin and in eczematous skin [38]. In the same line, in our co labeling experiment in HNSCC, most of the CTIP2 positive cells were also found to be co-labeled with Ki-67 (Fig. 3B, see double positive yellow cells). Altogether, our results with K10 and Ki-67 shows that CTIP2 expression is linked to tumor differentiation state and proliferation. Poorly differentiated tumors which are less differentiated contain more proliferative cells, and hence have higher CTIP2 expression. These results on cytokeratin 10 and Ki-67 staining pattern confirms that CTIP2 is linked to differentiation status of the tumor. Less differentiated tumor (poorly differentiated tumors) express high CTIP2 levels with proliferative nature (colabel with Ki-67) and express very low levels of cytokeratin K10.
###end p 82
###begin title 83
Co-staining of CTIP2, cytokeratin 10 and Ki-67 using immunofluorescence.
###end title 83
###begin p 84
(A) Co-staining of CTIP2 and differentiation marker cytokeratin 10 in dysplasia and in moderately differentiated tumor. CTIP2 in green, Cytokeratin 10 in red and DAPI in blue. Yellow dotted lines represents the margin of epidermis and dermis. (B) Co-staining of CTIP2 and a proliferation marker Ki-67 in poorly differentiated tumor. Insets are in yellow boxes and are magnified. Yellow arrows shows the CTIP2-Ki-67 double positive cells. (Original Magnification: 20x).
###end p 84
###begin title 85
###xml 44 49 <span type="species:ncbi:9606">human</span>
Expression of different CTIP2 transcript in human HNSCC
###end title 85
###begin p 86
###xml 270 275 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 365 372 365 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g003">Fig. 3A</xref>
###xml 414 419 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 444 449 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 461 462 461 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 461 462 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>L</sub></italic>
###xml 461 462 461 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic><sub>L</sub></italic></bold>
###xml 511 516 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 520 525 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 527 534 527 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g003">Fig. 3A</xref>
###xml 585 590 585 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 636 641 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 641 642 641 642 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 641 642 641 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>L</sub></italic>
###xml 641 642 641 642 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic><sub>L</sub></italic></bold>
###xml 647 652 647 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 744 749 744 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPLPO</italic>
###xml 985 990 985 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 990 991 990 991 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 990 991 990 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>L</sub></italic>
###xml 990 991 990 991 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic><sub>L</sub></italic></bold>
###xml 1037 1042 1037 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 1048 1055 1048 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g003">Fig. 3A</xref>
###xml 1164 1180 1164 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">material methods</xref>
###xml 1629 1634 1629 1634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 1634 1635 1634 1635 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 1634 1635 1634 1635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>L</sub></italic>
###xml 1634 1635 1634 1635 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic><sub>L</sub></italic></bold>
###xml 1641 1648 1641 1648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g004">Fig. 4A</xref>
###xml 1653 1660 1653 1660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005367-t002">Table 2</xref>
###xml 1726 1731 1726 1731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 1895 1902 1895 1902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005367-g004">Fig. 4B</xref>
###xml 1907 1914 1907 1914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005367-t002">Table 2</xref>
###xml 1992 1997 1992 1997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 2036 2041 2036 2041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 264 269 <span type="species:ncbi:9606">Human</span>
###xml 1355 1363 <span type="species:ncbi:9606">patients</span>
Since the CTIP2 antibody we used in our earlier experiments could not distinguish between the specific CTIP2 isoforms by IHC, we were interested to learn which isoform(s) of CTIP2 were relevant to HNSCC disease progression by quantitative real time PCR (qRT-PCR). Human CTIP2 has three alternatively spliced transcript variants, which encode distinct isoforms (see Fig. 3A). In our present study, we have referred CTIP2 with all the 4 exons as CTIP2 long (CTIP2L), the variant lacking exon3 which is the actual CTIP2 as CTIP2 (Fig. 3A), and the variant which lacks both Exon2 and 3 as CTIP2 short (not shown). qRT-PCR was performed for CTIP2L and CTIP2, on RNA extracted from 28 different HNSCC samples and amplifications were normalized using RPLPO as an internal control. We also included 10 normal uvulas to compare the expression levels of the transcripts along with HNSCC samples. To distinguish between the two forms, we have designed specific primers from exon 2 and exon 3 for CTIP2L, and exon 2 and overlapping exon 2 and 4 for CTIP2 (see Fig. 3A). The samples from different tumor size (T size), Tumor staging (T staging) and differentiation status (see material methods for details) were divided into early cancer (1-2) and late cancer (2-4), respectively. A significant number of samples with normal to high mRNA expression was observed among patients with T1-T4 tumor size and with well, moderate to poor differentiation status, and regional metastasis. However, statistical studies showed no statistical significance of any correlation between mRNA expression and any of the clinicopathological parameters with the CTIP2L (see Fig. 4A and Table 2). On the contrary, there was a significant correlation of higher CTIP2 expression with a poorer histological grade of the tumor, and a trend was noted in a relationship between expression and advanced tumor (T size) or Tumor staging (Fig. 4B and Table 2) (P<0.05). Altogether, these results suggest that although both the forms of CTIP2 are elevated in HNSCC only the actual CTIP2 is linked to the poor differentiation status of the tumor.
###end p 86
###begin title 87
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 58 64 58 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2<sub>L</sub></italic>
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
Scheme of CTIP2 transcripts and the expression pattern of CTIP2L and CTIP2 in HNSCC.
###end title 87
###begin p 88
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 94 99 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 106 107 106 107 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 106 107 106 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>L</sub></italic>
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 349 354 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 368 373 368 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 400 406 400 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n&#8202;=&#8202;28</italic>
###xml 552 557 552 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPLPO</italic>
###xml 667 672 665 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 23 28 <span type="species:ncbi:9606">human</span>
(A) Two transcripts of human CTIP2 are shown. CTIP2 with all the 4 exons, is the long form of CTIP2 (CTIP2L), and, lacking exon 3 is the actual CTIP2. Primers for the long form were taken from Exon 2 for Forward and exon 3 for reverse, and for the shorter form, the forward from boundary of Exon 2 & 4 and the reverse from exon 4. Expression of the CTIP2 long (B) and CTIP2 (C), by qRT-PCR in HNSCC (n = 28) and 10 normal uvulas based on T size, Tumor staging, and differentiation status. Plotted are the Relative quantification levels normalized with RPLPO as S.E.M+/-. p values were not significant between the groups in (B) but a significant correlation of higher CTIP2 expression was observed with a poorer histological grade of the tumor, and a trend was noted in a relationship between expression and advanced T or clinical stage in (C) [P<0.05].
###end p 88
###begin title 89
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
Correlation between CTIP2 mRNA expression levels and Clinicopathological characteristics in HNSCC.
###end title 89
###begin p 90
###xml 51 71 51 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">material and methods</xref>
Statistical analysis was performed as described in material and methods sections.
###end p 90
###begin title 91
Discussion
###end title 91
###begin p 92
###xml 238 243 <span type="species:ncbi:9606">human</span>
In the present study, we demonstrated for the first time over-expression of transcriptional regulatory protein CTIP2 in head and neck squamous cell carcinomas using IHC and qRT-PCR analysis. CTIP2 overexpression was detected in different human HNSCC cell lines as well as in HNSCC tumor specimens of different grades and/or differentiation stages. The protein was detected in several HNSCC cell lines, besides a breast adenocarcinoma cell line (MCF7), and its expression was relatively low compared to an internal control. Highest level of expression was observed in HSC2 (oral) and A253 (salivary gland) cells, and the lowest in SCC9 and Cal 33 (tongue), KB (mouth), Hep2 (larynx) and RPMI 2650 (nasal septum). The variation in the level of expression among different lines may depend on factors such as tumor stage and/or differentiation status of the tumor cell lines.
###end p 92
###begin p 93
###xml 767 768 767 768 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 893 894 893 894 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 888 894 888 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2<sub>L</sub></italic>
###xml 929 934 929 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 936 941 936 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
###xml 1005 1010 1005 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTIP2</italic>
In tumor sections, CTIP2 protein expression was associated with histological changes such as proliferation and differentiation, and its increased expression was linked to poorer differentiation status of those tumors. We were able to detect expression of CTIP2 protein in normal epithelium and in tumor cells with HNSCC characteristics within the same tissue sections. Intensities of staining increased from well, moderately to poorly differentiated tumors. Dramatic increase in CTIP2 expression was found in dysplasia where expression was observed all the way up to the differentiating cell layers, compared to the normal where expression was restricted to the basal cell layer. We also determined the expression pattern of the two different isoforms of CTIP2 [CTIP2L and CTIP2] in progression of HNSCC, using qRT-PCR analyses and by designing primer specific for each isoform. Although CTIP2L was elevated in HNSCC, the actual CTIP2 (CTIP2) was found to be more relevant to the disease progression. The CTIP2 mRNA level correlated well with the protein expression level obtained by IHC and western.
###end p 93
###begin p 94
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Prince1">[36]</xref>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Korkaya1">[39]</xref>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Golonzhka1">[19]</xref>
###xml 630 634 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Golonzhka1">[19]</xref>
###xml 793 797 793 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Mack1">[34]</xref>
###xml 816 820 816 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Prince2">[37]</xref>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 409 414 <span type="species:ncbi:10090">mouse</span>
It was recently demonstrated that human HNSCC contain tumorigenic cancer stem cells (CSC) with an ability to self renew and differentiate [36], [39]. In the same line, co-labeling experiments with CTIP2 and CSC marker BMI1 highlighted the existence of a distinct subset of cancer cells (BMI1+/CTIP2+) with possible stem cell characteristics. It has been already shown that CTIP2 is widely expressed in normal mouse skin [19]. Some, but not all, of the cells present within hair follicle bulge were also found to co-express CTIP2, keratin K15, but not CD34, indicating that a subset of K15+ CD34- skin stem cells may express CTIP2 [19]. It is possible that CTIP2 might regulate a subset of epithelial stem cell population in skin as well as in HNSCC. Recent contradictory reports on widespread [34] versus restricted [37] expression pattern of CSC marker CD44 in HNSCC has opened up discussion to identify novel CSC markers in this cancer type. The present study underscores the possible use of CTIP2 and BMI1 co-labeling to identify cancer stem cells (CSC) in HNSCC and suggests a transcriptional regulation of Bmi1 gene by CTIP2. The mechanisms of differential expression of CTIP2 and regulation of gene expression by CTIP2 in HNSCC remain to be elucidated.
###end p 94
###begin p 95
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-MacLeod1">[40]</xref>
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Kamimura1">[41]</xref>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Golonzhka2">[21]</xref>
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-GanguliIndra1">[38]</xref>
###xml 1267 1271 1267 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005367-Lu1">[42]</xref>
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
###xml 99 104 <span type="species:ncbi:9606">human</span>
###xml 270 274 <span type="species:ncbi:10090">Mice</span>
###xml 439 444 <span type="species:ncbi:9606">human</span>
###xml 500 508 <span type="species:ncbi:9606">patients</span>
###xml 1080 1085 <span type="species:ncbi:10090">Mouse</span>
###xml 1096 1101 <span type="species:ncbi:9606">human</span>
###xml 1306 1311 <span type="species:ncbi:10090">mouse</span>
CTIP2 protein is already known for its involvement in T-cell lymphomas and implicated in mouse and human leukemias [40]. CTIP2 is also known to make the DNA more vulnerable to replication stress and damages, thus being involved in maintenance of genomic stability [41]. Mice with a germ line deletion of the CTIP2 die after birth and exhibit defects in epidermal proliferation and terminal differentiation [21]. CTIP2 is also expressed in human skin and is upregulated in skin from atopic dermatitis patients [38]. Since CTIP2 has a role in maintenance of skin homeostasis, it could play a significant role in regulating proliferation and differentiation of the tumor cells in HNSCC. In the present study we found lower CTIP2 expression in more differentiated tumor type and CTIP2 expression increased with loss of differentiation. Moreover, most of the Ki-67 positive cells also were positive for CTIP2, indicating proliferative potential of CTIP2 positive cells. However, the underlying molecular mechanisms and role of this protein in epithelial carcinogenesis is yet unknown. Mouse models of human cancer play an important role in understanding the mechanisms of carcinogenesis and have accelerated the search for finding new molecular targets for cancer therapy [42]. Therefore, generating transgenic mouse model of CTIP2 overexpression using epithelial specific promoter would be a useful tool to study the role of CTIP2 in understanding the molecular mechanisms of HNSCC development and progression.
###end p 95
###begin title 96
Supporting Information
###end title 96
###begin p 97
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
Expression of mouse Bmi1 in Ctip2 mutant embryonic skin by qRT-PCR. Reduced expression of Bmi1 was observed in the Ctip2 mutant mice. Plotted are the Relative quantification levels normalized with HPRT as mean+/-S.E.M. p values between wild type and Ctip2 mutant were significant (p<0.05).
###end p 97
###begin p 98
(0.60 MB EPS)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
We would like to thank Stephen Hyter for help in image acquisition and promoter analysis and Christiane V. Lohr of College of Veterinary Medicine for help with tumor staining analysis. We also thank Dr. Wayne Kradjan and Dr. Gary DeLander of the OSU College of Pharmacy for continuous support and encouragement.
###end p 100
###begin title 101
References
###end title 101
###begin article-title 102
Cancer statistics.
###end article-title 102
###begin article-title 103
Head and neck cancer: changing epidemiology, diagnosis, and treatment.
###end article-title 103
###begin article-title 104
Epidemiology and risk factors for head and neck cancer.
###end article-title 104
###begin article-title 105
Head and neck cancer.
###end article-title 105
###begin article-title 106
Cancer statistics, 2005.
###end article-title 106
###begin article-title 107
New approaches to the understanding of the molecular basis of oral cancer.
###end article-title 107
###begin article-title 108
###xml 51 59 <span type="species:ncbi:9606">patients</span>
The use of genetic markers in the clinical care of patients with head and neck cancer.
###end article-title 108
###begin article-title 109
Potential molecular prognostic markers for lymph node metastasis in head and neck squamous cell carcinoma.
###end article-title 109
###begin article-title 110
Prognostic relevance of molecular markers of oral cancer-a review.
###end article-title 110
###begin article-title 111
Current status of biomarkers in head and neck cancer.
###end article-title 111
###begin article-title 112
###xml 114 121 <span type="species:ncbi:9031">chicken</span>
Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors.
###end article-title 112
###begin article-title 113
###xml 9 16 <span type="species:ncbi:9031">chicken</span>
COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein.
###end article-title 113
###begin article-title 114
BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.
###end article-title 114
###begin article-title 115
CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene.
###end article-title 115
###begin article-title 116
Bcl11b is required for differentiation and survival of alphabeta T lymphocytes.
###end article-title 116
###begin article-title 117
BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression.
###end article-title 117
###begin article-title 118
Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.
###end article-title 118
###begin article-title 119
The BCL11 gene family: involvement of BCL11A in lymphoid malignancies.
###end article-title 119
###begin article-title 120
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Expression of COUP-TF-interacting protein 2 (CTIP2) in mouse skin during development and in adulthood.
###end article-title 120
###begin article-title 121
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis.
###end article-title 121
###begin article-title 122
Dual Role of COUP-TF-Interacting Protein 2 in Epidermal Homeostasis and Permeability Barrier Formation.
###end article-title 122
###begin article-title 123
Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.
###end article-title 123
###begin article-title 124
###xml 20 25 <span type="species:ncbi:9606">human</span>
Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours.
###end article-title 124
###begin article-title 125
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
TAF10 is required for the establishment of skin barrier function in foetal, but not in adult mouse epidermis.
###end article-title 125
###begin article-title 126
BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas.
###end article-title 126
###begin article-title 127
Salivary transcriptome diagnostics for oral cancer detection.
###end article-title 127
###begin article-title 128
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells.
###end article-title 128
###begin article-title 129
Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation.
###end article-title 129
###begin article-title 130
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.
###end article-title 130
###begin article-title 131
The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
###end article-title 131
###begin article-title 132
Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion.
###end article-title 132
###begin article-title 133
###xml 53 58 <span type="species:ncbi:9606">human</span>
"Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
###end article-title 133
###begin article-title 134
Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.
###end article-title 134
###begin article-title 135
CD44s and CD44v6 expression in head and neck epithelia.
###end article-title 135
###begin article-title 136
Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium.
###end article-title 136
###begin article-title 137
Cancer stem cells in head and neck squamous cell cancer.
###end article-title 137
###begin article-title 138
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.
###end article-title 138
###begin article-title 139
###xml 55 60 <span type="species:ncbi:9606">human</span>
Expression of COUP-TF-interacting protein 2 (CTIP2) in human atopic dermatitis and allergic contact dermatitis skin.
###end article-title 139
###begin article-title 140
Selective targeting of cancer stem cells: a new concept in cancer therapeutics.
###end article-title 140
###begin article-title 141
BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia.
###end article-title 141
###begin article-title 142
Lack of Bcl11b tumor suppressor results in vulnerability to DNA replication stress and damages.
###end article-title 142
###begin article-title 143
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 17 22 <span type="species:ncbi:9606">human</span>
Mouse models for human head and neck squamous cell carcinomas.
###end article-title 143
###begin p 144
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
###xml 108 113 <span type="species:ncbi:9606">human</span>
Competing Interests: A provisional patent application has been filed related to CTIP2 expression pattern in human HNSCC.
###end p 144
###begin p 145
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The project described was supported by Award Number R01AR056008 from the National Institute of Arthritis And Musculoskeletal And Skin Diseases (NIAMS) to AI and by a NIEHS Center grant (ES00210) to the OSU Environmental Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 145

